Practice-Changing Data on Low ER+ Breast Tumors?
The immune landscape for low and intermediate estrogen receptor-positive breast tumors appears to mimic that for triple-negative tumors, suggesting a potential role for immunotherapy.
Medscape Medical News
source https://www.medscape.com/viewarticle/992641?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/992641?src=rss
Comments
Post a Comment